Stock Screener App

Frei -

0.56

6.01% -0.0358

IGC Pharma Inc (IGC)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

IGC Pharma Inc Aktie (IGC) Neueste Nachrichten

Top investors say IGC Pharma Inc (IGC) ticks everything they need – Sete News - SETE News

6.7 Million Americans Live With Alzheimerâ€™s â€“ IGC Pharma Believes They Deserve Treatment Options Without ... - Marketscreener.com

Marketscreener.com

6.7 Million Americans Live With Alzheimer's – IGC Pharma Believes They Deserve Treatment Options Without Black ... - Nasdaq

Wall Street analysts' outlook for IGC Pharma Inc (IGC) – Sete News - SETE News

Was there any good news for IGC Pharma Inc (IGC) stock in the last session? – US Post News - US Post News

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheim - Benzinga

IGC Pharma Adds Advisor in Artificial Intelligence - Business Wire

India Globalization Capital: Breakthrough in Alzheimer's Treatment Trial - TipRanks.com - TipRanks

IGC PHARMA INC Trade Ideas — GETTEX:IGS1 — TradingView - TradingView

Where Will IGC Pharma Inc (IGC) Stock Go Next After It Has Risen 15.79% in a Week? - InvestorsObserver

InvestorsObserver

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock - Business Wire

IGC Pharma reports promising Alzheimer's treatment results By Investing.com - Investing.com

IGC Pharma Appoints Terry Lierman as an Independent Director to its Board of Directors - citybiz

Igc Pharma reports enhanced memory function with TGR-63 an Alzheimer's mouse model - BioWorld Online

BioWorld Online

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target - Yahoo Finance

IGC Pharma reports higher net losses amid revenue dip in Q3 - Green Market Report

Green Market Report

IGC Pharma Reports Third Quarter Fiscal 2024 Results - Yahoo Finance

Igc's TGR-63 helps normalize emotional and behavioral responses in Alzheimer's model - BioWorld Online

BioWorld Online

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model - Business Wire

Why IGC Pharma Stock Is Moving Higher - IGC Pharma (AMEX:IGC) - Benzinga

IGC Pharma doses first patient with Alzheimer's therapy - Clinical Trials Arena

Clinical Trials Arena

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer's - Yahoo Finance

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials - Business Wire

IGC Pharma Signs Master Agreement with Leading South American University - AiThority

IGC signs agreement to adopt AI solutions into drug discovery - Pharmaceutical Technology

Pharmaceutical Technology

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives - Business Wire

IGC powers Alzheimer's and cannabis research with AI - Clinical Trials Arena

Clinical Trials Arena

IGC Pharma adds University of Puerto Rico to IGC-AD1 trial sites - Clinical Trials Arena

Clinical Trials Arena

IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia ... - Business Wire

IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research - Yahoo Finance

IGC Pharma Announces a $3 Million Private Placement of its Common Stock - Business Wire

IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - GlobeNewswire

IGC starts clinical trial of drug candidate to treat agitation in dementia - Clinical Trials Arena

Clinical Trials Arena

India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits - Business Wire

All the potential red flags for investors in IGC, the pot stock that jumped 1,000% in three months - MarketWatch

Dubious pot stock IGC has trading suspended, shares to be delisted - MarketWatch

$77.56

0.77%

$149.40

1.20%

$29.98

1.11%

$172.85

1.06%

$365.81

2.87%

$90.61

2.55%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen